Testing AI to catch glaucoma early in people with diabetes

Glaucoma is an eye disease that can cause blindness, but it often has no symptoms in its early stages. This study tests whether using artificial intelligence to analyze eye photos—combined with a simple eye pressure measurement—can catch glaucoma earlier in people with diabetes, who are at higher risk. The goal is to make screening easier and more accessible by adding glaucoma detection to eye exams that people with diabetes are already getting.

People with diabetes have a higher risk of developing glaucoma, but many cases go undetected until significant vision damage has occurred. This trial exists to see if combining AI-based glaucoma screening with routine diabetic eye exams can help doctors catch the disease sooner, when treatment is most effective.